Silence Therapeutics (SLN) Change in Account Payables: 2019-2024
Historic Change in Account Payables for Silence Therapeutics (SLN) over the last 5 years, with Sep 2024 value amounting to -$18.5 million.
- Silence Therapeutics' Change in Account Payables fell 22.55% to -$18.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$66.2 million, marking a year-over-year decrease of 48.08%. This contributed to the annual value of $54,728 for FY2023, which is 96.94% down from last year.
- Latest data reveals that Silence Therapeutics reported Change in Account Payables of -$18.5 million as of Q3 2024, which was up 2.01% from -$18.9 million recorded in Q2 2024.
- Silence Therapeutics' Change in Account Payables' 5-year high stood at $3.1 million during Q2 2020, with a 5-year trough of -$18.9 million in Q2 2024.
- Over the past 3 years, Silence Therapeutics' median Change in Account Payables value was -$15.1 million (recorded in 2023), while the average stood at -$13.4 million.
- Per our database at Business Quant, Silence Therapeutics' Change in Account Payables spiked by 185.56% in 2020 and then tumbled by 2,712.01% in 2024.
- Silence Therapeutics' Change in Account Payables (Quarterly) stood at -$10.8 million in 2020, then crashed by 34.38% to -$14.5 million in 2021, then declined by 1.94% to -$14.8 million in 2022, then declined by 4.11% to -$15.4 million in 2023, then declined by 22.55% to -$18.5 million in 2024.
- Its last three reported values are -$18.5 million in Q3 2024, -$18.9 million for Q2 2024, and -$13.3 million during Q1 2024.